• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ-连环蛋白通过诱导1型肝细胞生长因子激活剂抑制剂(HAI-1)在调控癌细胞迁移中的新作用。

Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).

作者信息

Sechler Marybeth, Borowicz Stanley, Van Scoyk Michelle, Avasarala Sreedevi, Zerayesus Sereke, Edwards Michael G, Kumar Karuppusamy Rathinam Manoj, Zhao Xiangmin, Wu Pei-Ying, Tang Ke, Bikkavilli Rama Kamesh, Winn Robert A

机构信息

Cancer Biology Program, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045.

Division of Hematology and Oncology, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612.

出版信息

J Biol Chem. 2015 Jun 19;290(25):15610-15620. doi: 10.1074/jbc.M114.631820. Epub 2015 Apr 29.

DOI:10.1074/jbc.M114.631820
PMID:25925948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4505473/
Abstract

γ-Catenin (Plakoglobin), a well-described structural protein functioning at the adherens junctions and desmosomes, was shown to be either lost or weakly expressed in non-small cell lung cancer (NSCLC) cells and tumor tissues. However, the tumor suppressive affects of γ-catenin were not fully understood. In this study, we have identified a novel role for the affects of γ-catenin on non-small cell lung cancer (NSCLC) cell migration. Expression of γ-catenin in NSCLC cells resulted in reduced cell migration as determined by both scratch assays and trans-well cell migration assays. Moreover, the affects of γ-catenin on cell migration were observed to be p53-dependent. Mechanistically, the anti-migratory effects seen via γ-catenin were driven by the expression of hepatocyte growth factor activator inhibitor Type I (HAI-1 or SPINT-1), an upstream inhibitor of the c-MET signaling pathway. Furthermore, the re-expression of γ-catenin sensitized NSCLC cells to c-MET inhibitor-mediated growth inhibition. Taken together, we identify γ-catenin as a novel regulator of HAI-1, which is a critical regulator of HGF/c-MET signaling. Therefore, targeting γ-catenin-mediated HAI-1 expression might be a useful strategy to sensitize NSCLC to c-MET inhibitors.

摘要

γ-连环蛋白(桥粒斑珠蛋白)是一种在黏着连接和桥粒中发挥作用的结构蛋白,已有充分描述。研究表明,它在非小细胞肺癌(NSCLC)细胞和肿瘤组织中缺失或表达较弱。然而,γ-连环蛋白的肿瘤抑制作用尚未完全明确。在本研究中,我们确定了γ-连环蛋白对非小细胞肺癌(NSCLC)细胞迁移作用的新机制。通过划痕实验和Transwell细胞迁移实验测定,NSCLC细胞中γ-连环蛋白的表达导致细胞迁移减少。此外还观察到,γ-连环蛋白对细胞迁移的影响依赖于p53。从机制上讲,γ-连环蛋白介导的抗迁移作用是由肝细胞生长因子激活剂抑制剂I型(HAI-1或SPINT-1)的表达驱动的,HAI-1是c-MET信号通路的上游抑制剂。此外,γ-连环蛋白的重新表达使NSCLC细胞对c-MET抑制剂介导的生长抑制敏感。综上所述,我们确定γ-连环蛋白是HAI-1的新型调节因子,而HAI-1是HGF/c-MET信号通路的关键调节因子。因此,靶向γ-连环蛋白介导的HAI-1表达可能是使NSCLC对c-MET抑制剂敏感的有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/22db51169324/zbc0281518890007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/2047006f8bf9/zbc0281518890001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/f28eca0b11aa/zbc0281518890002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/dd484e3e5aaf/zbc0281518890003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/f23f003b56e2/zbc0281518890004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/c2cae32dd635/zbc0281518890005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/eac9c8d97d08/zbc0281518890006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/22db51169324/zbc0281518890007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/2047006f8bf9/zbc0281518890001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/f28eca0b11aa/zbc0281518890002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/dd484e3e5aaf/zbc0281518890003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/f23f003b56e2/zbc0281518890004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/c2cae32dd635/zbc0281518890005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/eac9c8d97d08/zbc0281518890006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3be/4505473/22db51169324/zbc0281518890007.jpg

相似文献

1
Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).γ-连环蛋白通过诱导1型肝细胞生长因子激活剂抑制剂(HAI-1)在调控癌细胞迁移中的新作用。
J Biol Chem. 2015 Jun 19;290(25):15610-15620. doi: 10.1074/jbc.M114.631820. Epub 2015 Apr 29.
2
Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.肝细胞生长因子/分散因子、其激活剂、抑制剂及c-Met受体在人类癌细胞中的表达
Int J Oncol. 2001 Oct;19(4):857-63.
3
ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.ETS2 在人非小细胞肺癌中发挥肿瘤抑制功能和抑制 MET 癌基因。
Clin Cancer Res. 2013 Jul 1;19(13):3383-95. doi: 10.1158/1078-0432.CCR-13-0341. Epub 2013 May 9.
4
Plakoglobin restores tumor suppressor activity of p53 mutant by sequestering the oncogenic potential of β-catenin.桥粒芯糖蛋白通过隔离 β-连环蛋白的致癌潜能来恢复 p53 突变体的肿瘤抑制活性。
Cancer Sci. 2018 Jun;109(6):1876-1888. doi: 10.1111/cas.13612. Epub 2018 May 23.
5
Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.Met 和肝细胞生长因子的共过表达促进 NCI-H460 非小细胞肺癌细胞的全身转移。
Neoplasia. 2009 Dec;11(12):1292-300. doi: 10.1593/neo.09622.
6
gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.γ-连环蛋白在一部分人类肺癌中表达降低或缺失,其重新表达会抑制转化细胞的生长。
Oncogene. 2002 Oct 24;21(49):7497-506. doi: 10.1038/sj.onc.1205963.
7
Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.桥粒斑蛋白通过抑制人肺癌中的 Wnt/β-连环蛋白信号通路发挥抑癌作用。
Carcinogenesis. 2012 Oct;33(10):1863-70. doi: 10.1093/carcin/bgs226. Epub 2012 Jul 12.
8
MicroRNA‑200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c‑Met signaling pathway.微小 RNA-200a 通过抑制 HGF/c-Met 信号通路抑制 NSCLC 细胞的迁移和侵袭并增强其放射敏感性。
Oncol Rep. 2019 Mar;41(3):1497-1508. doi: 10.3892/or.2018.6925. Epub 2018 Dec 12.
9
Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.肿瘤抑制性p53信号增强转移性抑制剂KLF17依赖性转录以克服非小细胞肺癌中的肿瘤发生。
J Biol Chem. 2015 Aug 28;290(35):21336-51. doi: 10.1074/jbc.M114.635730. Epub 2015 Apr 24.
10
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer.HGF/c-MET 通路是非小细胞肺癌中血管内皮生长因子受体抑制剂耐药和血管重构的驱动因素和生物标志物。
Clin Cancer Res. 2017 Sep 15;23(18):5489-5501. doi: 10.1158/1078-0432.CCR-16-3216. Epub 2017 May 30.

引用本文的文献

1
Junction Plakoglobin - A Dual-Role Player in Cancer Biology.桥粒斑珠蛋白——癌症生物学中的双重角色参与者
Int J Surg. 2025 Jun 1;111(6):3920-3930. doi: 10.1097/JS9.0000000000002365. Epub 2025 Apr 1.
2
Thermodynamics of unfolding mechanisms of mouse mammary tumor virus pseudoknot from a coarse-grained loop-entropy model.从粗粒度环熵模型预测鼠乳腺肿瘤病毒假结解折叠机制的热力学。
J Biol Phys. 2022 Jun;48(2):129-150. doi: 10.1007/s10867-022-09602-2. Epub 2022 Apr 20.
3
Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast Carcinoma.

本文引用的文献

1
Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine).使用地西他滨(5-氮杂-2'-脱氧胞苷)对非小细胞肺癌进行表观遗传学治疗。
Front Oncol. 2013 Jul 29;3:188. doi: 10.3389/fonc.2013.00188. eCollection 2013.
2
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies.非小细胞肺癌:分子靶向治疗与个性化医疗——耐药性、机制及策略
Pharmgenomics Pers Med. 2013 Apr 4;6:25-36. doi: 10.2147/PGPM.S26058. Print 2013.
3
Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ.
SPINT1/2在乳腺癌中的表达及预后价值的综合分析
Front Endocrinol (Lausanne). 2021 Jul 26;12:665666. doi: 10.3389/fendo.2021.665666. eCollection 2021.
4
HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization.HAI-1 是肺癌死亡率的独立预测因子,并且是 M1 巨噬细胞极化所必需的。
PLoS One. 2021 Jun 29;16(6):e0252197. doi: 10.1371/journal.pone.0252197. eCollection 2021.
5
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma.连接斑蛋白调节和破坏 HIF2α 以抑制肾细胞癌的肿瘤发生。
Cancer Commun (Lond). 2021 Apr;41(4):316-332. doi: 10.1002/cac2.12142. Epub 2021 Feb 16.
6
Effects of differential distributed-JUP on the malignancy of gastric cancer.差异分布的JUP对胃癌恶性程度的影响。
J Adv Res. 2020 Jul 6;28:195-208. doi: 10.1016/j.jare.2020.06.026. eCollection 2021 Feb.
7
The Rho-guanine nucleotide exchange factor Solo decelerates collective cell migration by modulating the Rho-ROCK pathway and keratin networks.Rho 鸟嘌呤核苷酸交换因子 Solo 通过调节 Rho-ROCK 通路和角蛋白网络来减缓细胞的集体迁移。
Mol Biol Cell. 2020 Apr 1;31(8):741-752. doi: 10.1091/mbc.E19-07-0357. Epub 2020 Feb 12.
8
Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.描绘前列腺和卵巢上皮细胞中的HMGB1和HMGB2相互作用组及其与癌症的关系。
Oncotarget. 2018 Apr 10;9(27):19050-19064. doi: 10.18632/oncotarget.24887.
9
Plakoglobin restores tumor suppressor activity of p53 mutant by sequestering the oncogenic potential of β-catenin.桥粒芯糖蛋白通过隔离 β-连环蛋白的致癌潜能来恢复 p53 突变体的肿瘤抑制活性。
Cancer Sci. 2018 Jun;109(6):1876-1888. doi: 10.1111/cas.13612. Epub 2018 May 23.
10
The role of desmosomes in carcinogenesis.桥粒在致癌过程中的作用。
Onco Targets Ther. 2017 Aug 14;10:4059-4063. doi: 10.2147/OTT.S136367. eCollection 2017.
桥粒斑蛋白与转录因子 p53 相互作用,并调节 14-3-3σ 的表达。
J Cell Sci. 2013 Jul 15;126(Pt 14):3031-42. doi: 10.1242/jcs.120642. Epub 2013 May 17.
4
Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.肝细胞生长因子激活物抑制剂 1 是肠道肿瘤发生的抑制剂。
Cancer Res. 2013 Apr 15;73(8):2659-70. doi: 10.1158/0008-5472.CAN-12-3337. Epub 2013 Feb 27.
5
MET as a possible target for non-small-cell lung cancer.间变性淋巴瘤激酶(MET)作为非小细胞肺癌的一个可能的治疗靶点。
J Clin Oncol. 2013 Mar 10;31(8):1089-96. doi: 10.1200/JCO.2012.43.9422. Epub 2013 Feb 11.
6
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.5-氮杂-2'-脱氧胞苷(地西他滨)在癌症治疗方案设计中的药代动力学和药效学分析。
Clin Epigenetics. 2013 Feb 1;5(1):3. doi: 10.1186/1868-7083-5-3.
7
MET signaling: novel targeted inhibition and its clinical development in lung cancer.MET 信号通路:肺癌中新型靶向抑制及其临床开发。
J Thorac Oncol. 2012 Feb;7(2):459-67. doi: 10.1097/JTO.0b013e3182417e44.
8
An overview of the c-MET signaling pathway.c-MET 信号通路概述。
Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19. doi: 10.1177/1758834011422556.
9
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.国家癌症报告:1975-2007 年癌症发病与死亡统计,重点介绍脑和神经系统肿瘤。
J Natl Cancer Inst. 2011 May 4;103(9):714-36. doi: 10.1093/jnci/djr077. Epub 2011 Mar 31.
10
Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity.缺乏桥粒斑蛋白导致致命性先天性大疱性表皮松解症:一种新的临床遗传实体。
Hum Mol Genet. 2011 May 1;20(9):1811-9. doi: 10.1093/hmg/ddr064. Epub 2011 Feb 14.